Top Markets
Coin of the day
Bioptik Technology Incorporation Bioptik Technology Incorporation

Bioptik Technology Incorporation

4161
Classifica tra le azioni #26080
Bioptik Technology Incorporation operates as a global entity, focusing on the... Bioptik Technology Incorporation operates as a global entity, focusing on the creation and distribution of medical instruments and diagnostic chemicals. The company's product line encompasses the EasyMate series of blood glucose monitoring systems, as well as comprehensive diagnostic devices designed to measure blood glucose, cholesterol, and uric acid levels, complete with their essential test strips. Beyond its healthcare offerings, Bioptik also provides a range of skincare solutions, including those formulated with hyaluronic acid, alongside various dietary supplements. Uniquely, the company diversifies its business by supplying biodiesel products. Founded in 1999, Bioptik Technology Incorporation is headquartered in Zhunan, Taiwan.
Prezzo delle azioni
$0.72978769
Capitalizzazione di mercato
$43.65M
Variazione (1 giorno)
1.10%
Variazione (1 anno)
-17.81%
Paese
TW
Scambia Bioptik Technology Incorporation (4161)

Categoria

Rapporto P/S per Bioptik Technology Incorporation (4161)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Bioptik Technology Incorporation, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Bioptik Technology Incorporation da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
4.13 -
US
5.03 -
US
2.78 -
IE
3.67 -
US
- -
DE